Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myxoid/Round Cell Liposarcoma”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT03063632
What this trial is testing

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Round Cell LiposarcomaMetastatic Synovial Sarcoma+13 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT02821507
What this trial is testing

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Who this might be right for
Conventional ChondrosarcomaMyxoid LiposarcomaMesenchymal Chondrosarcoma+1 more
Leiden University Medical Center 70
Early research (Phase 1)Ended earlyNCT04526509
What this trial is testing

Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors

Who this might be right for
Neoplasms
Adaptimmune 12
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Very early researchNot Yet RecruitingNCT07261657
What this trial is testing

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaSynovial Sarcoma
Northwestern University 8
Not applicableAvailableNCT06617572
What this trial is testing

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Who this might be right for
Synovial SarcomaMyxoid Liposarcoma
USWM CT, LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271
What this trial is testing

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more
Sotio Biotech Inc. 7
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT06083883
What this trial is testing

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Who this might be right for
Synovial SarcomaMyxoid/Round Cell Liposarcoma
M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT06703346
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM CT, LLC 87
Testing effectiveness (Phase 2)Study completedNCT01532687
What this trial is testing

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+16 more
OHSU Knight Cancer Institute 54
Early research (Phase 1)Looking for participantsNCT06644755
What this trial is testing

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorsSarcoma
Daiichi Sankyo 150
Not applicableNot Yet RecruitingNCT06526897
What this trial is testing

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Who this might be right for
Adult Pleomorphic RhabdomyosarcomaAJCC Grade 2 SarcomaAJCC Grade 3 Sarcoma+20 more
ECOG-ACRIN Cancer Research Group 1,582
Testing effectiveness (Phase 2)Study completedNCT00579501
What this trial is testing

Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma

Who this might be right for
Liposarcoma,Myxoid
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 29
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more
St. Jude Children's Research Hospital 139
Early research (Phase 1)Ended earlyNCT05943990
What this trial is testing

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
Adaptimmune 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Early research (Phase 1)Ended earlyNCT03399448
What this trial is testing

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Who this might be right for
Multiple MyelomaMelanomaSynovial Sarcoma+1 more
University of Pennsylvania 3
Testing effectiveness (Phase 2)Looking for participantsNCT06843967
What this trial is testing

Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Who this might be right for
Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more
Memorial Sloan Kettering Cancer Center 54
Load More Results